Zoldonrasib (RMC-9805; KRAS G12D inhibitor 18)
$300.00
CAS No.: 2922732-54-3
Catalog No.: 200075
Purity: 98%
MF: C63H88F3N11O7
MW: 1168.44
Storage: 2-8 degree Celsius
SMILES: C[C@H](OC)C1=NC=C(N2CCN(C3CC3)CC2)C=C1C4=C(CC(COC([C@H]5NN6CCC5)=O)(C)C)C7=C(C=CC(N8CCO[C@@H](C[C@@H](C6=O)NC([C@@H](N9C[C@]%10(CN(C([C@@H]%11N(C)[C@H]%11C%12CC%12)=O)CC%10)CC9)C%13CCCC%13)=O)C8)=C7)N4CC(F)(F)F
Catalog No.: 200075
Purity: 98%
MF: C63H88F3N11O7
MW: 1168.44
Storage: 2-8 degree Celsius
SMILES: C[C@H](OC)C1=NC=C(N2CCN(C3CC3)CC2)C=C1C4=C(CC(COC([C@H]5NN6CCC5)=O)(C)C)C7=C(C=CC(N8CCO[C@@H](C[C@@H](C6=O)NC([C@@H](N9C[C@]%10(CN(C([C@@H]%11N(C)[C@H]%11C%12CC%12)=O)CC%10)CC9)C%13CCCC%13)=O)C8)=C7)N4CC(F)(F)F
For R&D use only. Not for human or animal use.
Zoldonrasib (RMC-9805; KRAS G12D inhibitor 18) CAS No.: 2922732-54-3 is a potent and orally active KRAS G12D inhibitor.Zoldonrasib induces apoptosis in KRAS G12D mutant cancer cells. Zoldonrasib has the potential for the research of KRAS G12D mutant cancer.
Related Products:
Daraxonrasib (RMC-6236) CAS No.: 2765081-21-6 https://www.chemshuttle.com/catalogsearch/result/?q=2765081-21-6&cat=
RMC-7977 CAS No.: 2765082-12-8 https://www.chemshuttle.com/catalogsearch/result/?q=2765082-12-8&cat=
RMC-4998 CAS No.: 2642037-07-6 https://www.chemshuttle.com/catalogsearch/result/?q=2642037-07-6&cat=
Elironrasib (RMC-6291) CAS No.: 2641998-63-0 https://www.chemshuttle.com/catalogsearch/result/?q=2641998-63-0&cat=
RMC-5127 CAS No.: 3056146-38-1 https://www.chemshuttle.com/catalogsearch/result/?q=3056146-38-1&cat=
RM-018 CAS No.: 2641993-55-5 https://www.chemshuttle.com/catalogsearch/result/?q=2641993-55-5&cat=
RAS/RAS-RAF-IN-1 CAS No.: 2447039-81-6 https://www.chemshuttle.com/catalogsearch/result/?q=2447039-81-6&cat=
Reviews
Write Your Own Review